Purchase Dimethylphenidate
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy Dimethylphenidate for sale
Dimethylphenidate is a psychostimulant and a close analog of Methylphenidate, Ethylphenidate, and Propylphenidate. These drugs have similar effects to amphetamine but are structurally different.
Dimethylphenidate (DMP) is a psychostimulant drug of the phenethylamine and amphetamine classes that produces long-lasting monoamine neurotransmitter release by inhibiting the reuptake of norepinephrine, dopamine and serotonin.
Dimethylphenidate hydrochloride is a psychostimulant and a close analog of Methylphenidate and Ethylphenidate. It has been used to treat ADHD and fatigue in cancer patients, although its oral bioavailability is markedly reduced by first-pass metabolism, making it more suited for IV administration.
Dimethylphenidate is a stimulant drug primarily used to treat attention deficit hyperactivity disorder (ADHD) and fatigue in cancer patients. It should not be prescribed for people with a history of addiction to drugs such as amphetamines, as there is potential for abuse.
DMPH is an amphetamine stimulant that can be ingested orally, inhaled, snorted or injected via IV. Health professionals often use it to administer to those with ADHD.
Dimethylphenidate hydrochloride is a psychostimulant of the phenethylamine and piperidine classes. It is said to have roughly twice the potency of methylphenidate and methylphenidate by weight, though some users report up to three times as much. It has similar pharmacological effects to the compounds mentioned above, though with a slower onset due to its primary amine being metabolized into an ethyl group on ingestion.
Dimethylphenidate is a psychostimulant and a close analog of Methylphenidate and Ethylphenidate. It reportedly has lower abuse potential than methylphenidate but was initially developed as a replacement for amphetamine when its use in society became too prevalent.
DMP is a psychostimulant and close analog of Methylphenidate and Ethylphenidate that may have lower abuse potential than methylphenidate. DMP was initially developed as a replacement for amphetamine, which became prevalent when it was replaced in society.
D-MPH is a psychostimulant. It is thought to have less potential for abuse than Methylphenidate (Ritalin) or Ethylphenidate, but it is used clinically to treat the same disorders.
1,3-Dimethylphenidate is a psychostimulant that affects the brain similarly to methylphenidate and methylphenidate. This harmful substance can be used as a replacement for amphetamine, which is also found in certain prescription drugs.
Dimethylphenidate is a psychostimulant and a close analog of Ethylphenidate.
Dimethylphenidate is a prescription medication used to treat ADHD, the inability to focus or pay attention.
Dimethylphenidate is a stimulant drug of the substituted phenethylamine and amphetamine chemical classes that produce long-lived focusing effects and decreases fatigue while improving motivation, mental energy, and drive. It is closely related to methylphenidate but more potent. The pharmacokinetics of methylphenidate has not been studied in humans but are thought to be similar to methylphenidate.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $1590
1000 pills $45
100mg $840
500g $1390
1kg $1690
1kg $1690
out of stock
100g $390
100g $510
1kg $1690
1kg $1690
200g $690